Webcast

Life Disrupted: Role of Advanced Practice Providers in Guiding Patients with Crohn’s Disease Through the Challenges of Bowel Urgency

Launch Date
05/01/2024 at 6:30 pm EST
Credit Amount
1
Credit Expires
07/01/2024

Faculty

Kimberly Orleck, PA-C
PA-C at Atlanta Gastroenterology Associates
Chair of Education for Gastroenterology and Hepatology Advanced Practice (GHAPP)
Director of Advanced Practice Providers (APPs) for United Digestive
Amar Naik, MD
Director of Inflammatory Bowel Disease Program
Founding Partner, Midwest Digestive Health & Nutrition
Des Plaines, IL
Susan T. Wolgamott, DNP, FNP-C, CTN-B
Family Nurse Practitioner
Scope Medical Group
Bloomfield Township, MI
Explore By Section
Statement of Need Learning Objectives Financial Support Target Audience Credit Information Disclosure Declaration Obtaining Credit

Statement of Need

Up to 80% of patients with Crohn’s disease (CD) report some degree of bowel urgency, a symptom that not only significantly adds to their overall emotional and social burden but can be an indicator of uncontrolled bowel inflammation. Unfortunately, bowel urgency is largely underrecognized by health care professionals (HCPs) caring for patients with CD. Nurse practitioners (NPs) and physician associates (PAs) in the gastroenterology field are positioned to initiate screening for bowel urgency as part of thorough symptom evaluation while establishing open communication with patients and implementing shared decision-making.

In this CME Outfitters live webcast, leading clinical experts will help prepare learners to discuss, assess, and address bowel urgency in patients with CD, and will provide insight into the efficacy and safety of new and emerging therapies. The webcast will also include videos capturing the patient journey and first-hand experiences.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Identify the contributions of bowel urgency, fatigue, psychosocial symptoms, and histologic/endoscopic healing in the burden of CD and their effects on patient QoL
  • Evaluate bowel urgency, fatigue, psychosocial symptoms, and histologic/endoscopic healing for patients with CD as part of thorough symptom evaluation
  • Engage patients in open communication about their bowel urgency, fatigue, psychosocial symptoms, and histologic/endoscopic healing with the goal of improving clinical outcomes

Financial Support

This activity is supported by an educational grant from Lilly.

Target Audience

Primary: gastroenterology nurse practitioners (NPs) and physician associates (PAs)
Secondary: nurses and pharmacists

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional (IPCE) 1.0

This activity was planned by and for the healthcare team, and learners will receive 1.00 Interprofessional Continuing Education Credit for learning and change.

Nurses (ANCC) 1.0

This activity is designated for 1.00 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters, LLC’s provider number is CEP15510.

Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

Pharmacists (ACPE) 1.0

This application-based activity is approved for 1.00 contact hours ( 0.1 CEUs) of continuing pharmacy credit (JA0007185-0000-24-027-L01-P).

PAs (AAPA) 1.00

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. Approval is valid until 07/01/2024. PAs should only claim credit commensurate with the extent of their participation.

Disclosure Declaration

Ms. Orleck reports the following financial relationships:

Advisory Board: AbbVie Inc.; Janssen Pharmaceuticals, Inc.; Lilly; and Salix Pharmaceuticals

Consultant: Bristol Myers Squibb Company and Pfizer Inc.

Speakers Bureau: AbbVie Inc.; Ardelyx; Janssen Pharmaceuticals, Inc.; Lilly; Salix Pharmaceuticals; and Takeda Pharmaceuticals U.S.A., Inc.

Dr. Naik reports the following financial relationships:

Consultant: AbbVie Inc.; Bristol Myers Squibb Company; Eli Lilly & Company; Pfizer Inc.; and Takeda Pharmaceuticals U.S.A., Inc.

Speakers Bureau: AbbVie Inc.; Bristol Myers Squibb Company; Eli Lilly & Company; and Takeda Pharmaceuticals U.S.A., Inc.

Dr. Wolgamott reports no financial relationships to disclose.

The following individuals have no financial relationships to disclose:

Amanda K. Smith, PA-C (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Susan Perry (Planning Committee)
Kasey Brandt, PharmD (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).

WC-083-050124-11

Life Disrupted: Role of Advanced Practice Providers in Guiding Patients with Crohn’s Disease Through the Challenges of Bowel Urgency
Event Date: 05/01/2024 at 6:30 pm EST
Begin